Benjamin C.

Benjamin C. is an experienced professional in the field of CMC Drug Substance, currently serving as Associate Director at Xencor since June 2021. With a diverse background in process engineering and drug development, Benjamin has authored IND Module 3 drug substance sections and managed various development activities for product candidates. Prior experience includes roles at Pfenex Inc., where Benjamin supported NDA filings and technology transfers, and at Gilead Sciences, leading validation efforts for external manufacturing operations. Benjamin began the career with roles at Genzyme, Shire, and as an independent researcher, demonstrating expertise in process investigations, development, and regulatory compliance. Educational credentials include a Master of Engineering in Bioengineering from Tufts University and a Bachelor of Science in Chemical Engineering from the University of New Hampshire.